US Stock MarketDetailed Quotes

Atossa Therapeutics (ATOS)

Watchlist
  • 0.6546
  • +0.0513+8.50%
Close Jan 22 16:00 ET
  • 0.6545
  • -0.0001-0.02%
Pre 08:04 ET
84.56MMarket Cap-2.85P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atossa Therapeutics (ATOS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
44.89%9.25M
27.23%9.04M
6.22%7.41M
-11.97%27.62M
-20.71%7.15M
-14.50%6.39M
-8.83%7.11M
-1.66%6.98M
13.31%31.38M
10.83%9.02M
Selling and administrative expenses
30.54%3.88M
-0.39%3.54M
0.77%3.26M
-3.84%13.5M
11.38%3.75M
-0.93%2.97M
-13.11%3.55M
-9.97%3.23M
11.38%14.04M
6.76%3.37M
-General and administrative expense
30.54%3.88M
-0.39%3.54M
0.77%3.26M
-3.84%13.5M
11.38%3.75M
-0.93%2.97M
-13.11%3.55M
-9.97%3.23M
11.38%14.04M
6.76%3.37M
Research and development costs
57.39%5.37M
54.86%5.5M
10.91%4.16M
-18.56%14.12M
-39.81%3.4M
-23.62%3.41M
-4.10%3.55M
6.84%3.75M
14.92%17.33M
13.40%5.65M
Operating profit
-44.89%-9.25M
-27.23%-9.04M
-6.22%-7.41M
11.97%-27.62M
20.71%-7.15M
14.50%-6.39M
8.83%-7.11M
1.66%-6.98M
-13.31%-31.38M
-10.83%-9.02M
Net non-operating interest income expense
-43.06%570K
-39.89%645K
-36.73%720K
-6.75%4.05M
-32.28%837K
-21.43%1M
9.16%1.07M
33.88%1.14M
395.21%4.34M
84.48%1.24M
Non-operating interest income
-43.06%570K
-39.89%645K
-36.73%720K
-6.75%4.05M
-32.28%837K
-21.43%1M
9.16%1.07M
33.88%1.14M
395.21%4.34M
84.48%1.24M
Other net income (expense)
99.40%-11K
-64.71%-28K
33.33%-24K
36.83%-1.93M
-213.79%-33K
-5,174.29%-1.85M
99.44%-17K
-9.09%-36K
-1,995.89%-3.06M
226.09%29K
Special income (charges)
--0
----
----
42.81%-1.71M
--0
---1.71M
--0
----
---2.99M
--0
-Write off
--0
----
----
-42.81%1.71M
--0
--1.71M
--0
----
--2.99M
--0
Other non- operating income (expenses)
91.91%-11K
-64.71%-28K
33.33%-24K
-218.57%-223K
-213.79%-33K
-288.57%-136K
43.33%-17K
-9.09%-36K
52.05%-70K
226.09%29K
Income before tax
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
Net income continuous Operations
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
Minority interest income
Net income attributable to the parent company
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
Basic earnings per share
-16.67%-0.07
-40.00%-0.07
0.00%-0.05
16.67%-0.2
16.67%-0.05
-20.00%-0.06
37.50%-0.05
0.00%-0.05
-14.29%-0.24
0.00%-0.06
Diluted earnings per share
-16.67%-0.07
-40.00%-0.07
0.00%-0.05
16.67%-0.2
16.67%-0.05
-20.00%-0.06
37.50%-0.05
0.00%-0.05
-14.29%-0.24
0.00%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 44.89%9.25M27.23%9.04M6.22%7.41M-11.97%27.62M-20.71%7.15M-14.50%6.39M-8.83%7.11M-1.66%6.98M13.31%31.38M10.83%9.02M
Selling and administrative expenses 30.54%3.88M-0.39%3.54M0.77%3.26M-3.84%13.5M11.38%3.75M-0.93%2.97M-13.11%3.55M-9.97%3.23M11.38%14.04M6.76%3.37M
-General and administrative expense 30.54%3.88M-0.39%3.54M0.77%3.26M-3.84%13.5M11.38%3.75M-0.93%2.97M-13.11%3.55M-9.97%3.23M11.38%14.04M6.76%3.37M
Research and development costs 57.39%5.37M54.86%5.5M10.91%4.16M-18.56%14.12M-39.81%3.4M-23.62%3.41M-4.10%3.55M6.84%3.75M14.92%17.33M13.40%5.65M
Operating profit -44.89%-9.25M-27.23%-9.04M-6.22%-7.41M11.97%-27.62M20.71%-7.15M14.50%-6.39M8.83%-7.11M1.66%-6.98M-13.31%-31.38M-10.83%-9.02M
Net non-operating interest income expense -43.06%570K-39.89%645K-36.73%720K-6.75%4.05M-32.28%837K-21.43%1M9.16%1.07M33.88%1.14M395.21%4.34M84.48%1.24M
Non-operating interest income -43.06%570K-39.89%645K-36.73%720K-6.75%4.05M-32.28%837K-21.43%1M9.16%1.07M33.88%1.14M395.21%4.34M84.48%1.24M
Other net income (expense) 99.40%-11K-64.71%-28K33.33%-24K36.83%-1.93M-213.79%-33K-5,174.29%-1.85M99.44%-17K-9.09%-36K-1,995.89%-3.06M226.09%29K
Special income (charges) --0--------42.81%-1.71M--0---1.71M--0-------2.99M--0
-Write off --0---------42.81%1.71M--0--1.71M--0------2.99M--0
Other non- operating income (expenses) 91.91%-11K-64.71%-28K33.33%-24K-218.57%-223K-213.79%-33K-288.57%-136K43.33%-17K-9.09%-36K52.05%-70K226.09%29K
Income before tax -20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M6.42%-5.88M-11.62%-30.09M-3.51%-7.75M
Income tax 0000000000
Net income -20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M6.42%-5.88M-11.62%-30.09M-3.51%-7.75M
Net income continuous Operations -20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M6.42%-5.88M-11.62%-30.09M-3.51%-7.75M
Minority interest income
Net income attributable to the parent company -20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M6.42%-5.88M-11.62%-30.09M-3.51%-7.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M6.42%-5.88M-11.62%-30.09M-3.51%-7.75M
Basic earnings per share -16.67%-0.07-40.00%-0.070.00%-0.0516.67%-0.216.67%-0.05-20.00%-0.0637.50%-0.050.00%-0.05-14.29%-0.240.00%-0.06
Diluted earnings per share -16.67%-0.07-40.00%-0.070.00%-0.0516.67%-0.216.67%-0.05-20.00%-0.0637.50%-0.050.00%-0.05-14.29%-0.240.00%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -